INIS
errors
100%
polymerases
100%
adp
100%
ribose
100%
therapy
33%
tumors
22%
repair
22%
mutations
22%
gene recombination
22%
data
11%
cancer
11%
solids
11%
clinical trials
11%
patients
11%
reviews
11%
defects
11%
kinases
11%
utilities
11%
investigations
11%
breasts
11%
cell cycle
11%
stabilization
11%
durability
11%
restoration
11%
ovaries
11%
Medicine and Dentistry
PARP Inhibitor
100%
Combination Therapy
33%
Epigenomics
22%
BRCA1
22%
Homologous Recombination
22%
Recombination Repair
22%
Neoplasm
11%
Breast Cancer
11%
Treatment Response
11%
Phosphoinositide 3-Kinase
11%
Ovarian Cancer
11%
Angiogenesis Inhibitor
11%
Solid Malignant Neoplasm
11%
Revertant
11%
Lethality
11%
Cell Cycle Checkpoint
11%
MEK Inhibitor
11%
Inpatient
11%
Clinical Trial
11%
Poly ADP Ribose Polymerase
11%
Biochemistry, Genetics and Molecular Biology
Poly ADP Ribose Polymerase
100%
Mutation
20%
Homologous Recombination
20%
BRCA1
20%
Recombination Repair
20%
Epigenetics
20%
Kinase
10%
Revertant
10%
Cell Cycle Checkpoint
10%
Synthetic Lethality
10%
Solid
10%
MEK Inhibitor
10%
Phosphatidylinositol
10%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
100%
Combination Therapy
22%
Breast Cancer
11%
Neoplasm
11%
Phosphatidylinositol 3 Kinase
11%
Solid Malignant Neoplasm
11%
Ovary Cancer
11%
Cell Cycle Checkpoint
11%
Angiogenesis Inhibitor
11%
Mitogen Activated Protein Kinase Kinase Inhibitor
11%
Lethality
11%